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Summary.-Acute inflammatory reactions were induced in rats by the intravenous
injection of cellulose sulphate (CS) or an extract of normal rat lung homogenate
(LH), or by intraperitoneal injections of Compound 48/80. These treatments greatly
increased survival and clonogenic growth in the lungs of rats of intravenously injec-
ted allogeneic W-256 and Y-P388 tumour cells. Increase in the dose of intraven-
ously injected CS caused a logarithmic increase in colony forming efficiency (CFE)
of tumour cells in the lungs. CFE was not stimulated by the intravenous injection
of rats with pharmacological mediators of inflammation (histamine, 5-hydroxy-
tryptamine, bradykinin and prostaglandins PGE1 and PGF2a) which are released
from tissues by agents which induce inflammation. Stimulation of CFE by CS
occurred in adrenalectomized rats but was inhibited by treatment of rats with an
anti-inflammatory steroid, dexamethasone. CFE was stimulated by CS in tumour
immunized rats; the inflammatory state did not prevent the expression of immunity
but " rescued " a proportion (approximately 20%) of the injected tumour cells from
immunodestruction in the lungs. A higher proportion of tumours grew in the
paws of rats when a small number of W-256 cells were injected interdigitally into the
acute inflammatory swellings produced by the local injection of paws with LH or CS.
CS is a " synthetic heparin " which causes marked prolongation of blood clotting
time and also increases fibrinolytic activity of the blood. Anticoagulant treatment
of rats with heparin did not affect CFE. Thus, there was no direct correlation
between blood clotting time and CFE of blood borne tumour cells in the rat.
The mechanisms which may be responsible for the nonspecific growth promoting
effects of inflammatory reactions induced by various types of tissue injury on tumour
induction and growth are discussed.
THE PROPORTION of intravenously in-
jected allogeneic tumour cells which sur-
vivedandformedmacrocoloniesinthelungs
of rats (colony forming efficiency, CFE)
is relatively small (less than 1%), but
CFE was greatly increased if the lungs of
recipients had been treated locally with
x-ravs before the tumour cells were
injected (van den Brenk, Sharpington and
Orton, 1973a; van den Brenk et al.,
1973b). In mice, local x-irradiation of
the lungs also stimulated CFE of intra-
venously injected syngeneic tumour cells
(Withers and Milas, 1973). Stimulation
of CFE in the lungs of rats by x-radiation
was inhibited by treatment with steroidal
and non-steroidal anti-inflammatory drugs
(van den Brenk et al., 1974). These
findings suggested that inflammatory reac-
tions produced by x-rays in lung tissues
were largely responsible for stimulation
of clonogenic growth of tumour cells in
the organ.
In this paper we describe experiments
in which tumour CFE was measured
in rats which were injected with Com-
pound 48/80, cellulose sulphate (CS) and
with a preparation of normal rat lung
homogenate (LH), which are agents that
induce inflammatorv reactions in tissues
by releasing autacoids, including hista-
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and prostaglandins, which act as pharma-
cological mediators of inflammation
(Brocklehurst, 1971; Di Rosa, Giroud and
Willoughby, 1971).
MATERIALS AND METHODS
Female Caworth Farm strain (SPF) rats
-were injected intravenously with single cell
suspensions of Walker (W-256) or Yoshida
(Y-P388) tumour cells. Lung tumour macro-
colonies were counted on the surfaces of the
lungs 7-8 days later, as described previously
(van den Brenk et al., 1973a). The number
of macrocolonies (NL) produced in the lungs
by the intravenous injection of N tumour
cells Aas counted in each rat to determine
CFE.
Supply a(id preparation of mediators of
inflwammioation and other agents
Cellulose ssulphate (CS)-.Synthetic poly-
saccharide sulphuric acids are potent anti-
coagulants referred to as synthetic hepa-
rins" (Bergstrom, 1935). They also cause
extensive plasma kininogen depletion with
the release of bradykinin in the rat (Roths-
child, 1968). Cellulose sulphate was pre-
pared from Whatman cellulose powder CC41
in microgranular form (W. & R. Balston
Ltd) using pyridine and chorosulphonic
acid, accoiding to the method of Astrup,
Galsmar and Volkert (1944); 2-5 g of the
powder yielded 9-1 g CS. CS was dissolved
in distilled water for intravenous injection
of rats.
Compound 48/80.-This substance is a
condensation product of p-methoxyphen-
ethyl-methylamine with formaldehyde; in-
jected into the mammal Compound 48/80
liberates tissue histamine (Paton, 1951) and
also 5-hydroxytryptamine, another mediator
of inflammation (Lewis, 1958). Compound
48/80 (Batch 46664) was kindly donated by
Wellcome Research Laboratories, Kent; it
was dissolved in distilled water for intra-
peritoneal or subcutaneous injection of
rats.
Other agents.-Other compounds used for
injection of animals were histamine phos-
phate and 5-hydroxytryptamine creatinine
sulphate (BDH Ltd) and dexamethasone
sodium phosphate (Decadron; Merck, Sharp
& Dohme Ltd). Bradykinin (BRS 640) was
kindly donated by Sandoz Ltd and pre-
servative-free mucousheparin wassuppliedby
Weddell Laboratories. ProstaglandinsPGE1 and PGF2a, generously made available by
Miss S. Taylor, Department ofPharmacology,
St Thomas' Hospital, were prepared in
alcoholic carbonate solution (pH 6-7.5) for
intravenous injections.
Rat tissue homnogenates.-Six- to 8-week
old rats were deeply anaesthetized with
pentobarbitone sodium and exsanguinated.
The lungs were removed, washed in saline
and weighed. They were then minced in
ice-cold isotonic saline (1 g lung in 2 ml
saline), homogenized and centrifuged at
2000 g. An aliquot of the supernatant was
used to determine the total protein concen-
tration using Folin's method (Lowry et
al., 1951). The remaining supernatant was
diluted with isotonic saline for intravenous
or subcutaneous injection of rats.
Biological and toxicity tests
(i) Blood: clotting and leucocyte counts.-
Rats were anaesthetized w%ith 35 mg pento-
barbitone sodium (Nembutal) per kg body
weight injected intraperitoneally, and 3 ml
ventricular heart blood was withdrawn into
a standard sized test tube. The clotting
time was determined at 21°C. The normal
range was 45-125 s under the conditions of
the test. Leucocyte counts were made in
venous blood using a Neubauer counting
chamber.
(ii) Rat paw inflammafion.-The inflam-
matory effects produced by Compound 48/80
and CS were determined by injecting 0 1 ml
of the solution of either agent into an inter-
digital space of one hind paw and 0-1 ml
distilled water into the contralateral paw of
lightly anaesthetized rats. Two observers
independently recorded changes in the colour,
surface temperature and swelling of the paws
at 5-15 min intervals for 1 h after injection.
The maximum inflammatory reaction pro-
duced in each paw was scored semi-quantita-
tively as: no effect (0), definite reddening,
warmth and swelling (+) or red, hot and
marked swelling (-++f). Two rats were used
for each dose ofthe compound tested.
(iii) Toxicity and lethality.-Groups of
rats were injected intravenously with CS
or preparations oflung homogenate in graded
amounts to determine the doses required to
kill 5000 of rats (LD50). Half of the LD50
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maximum tolerated dose (MTD). MTD for
Compound 48/80 was based on the findings
of Feldberg and Talesnik (1953) and on
previous experience in the use of this agent
in rats. Prostaglandins (PGE1 and PGF21)
uwere injected intravenously in doses of
1 mg/kg body weight. Both agents produced
shock, tachypnoea and dyspnoea, accom-
panied by vasodilatation (PGE1) or vaso-
constriction (PGF2.) of the skin, but the
rats appeared to have recovered completely
1 h later. Insufficient amounts of prosta-
glandin were available to estimate LD50 and
MTD dosages.
Adrenalectomy
Bilateral total adrenalectomy (TAX) or
bilateral medullary adrenalectomy (MAX)
w-ere performed under pentobarbitone anaes-
thesia through a midline dorsal approach
2 days before the rats were injected with
tumour cells. Rats subjected to TAX were
given daily subcutaneous injections of 1 mg
cortisone acetate, their diet was supple-
mented with dried peas and their drinking
water was replaced with 1% sodium chloride.
Incubation of W-256 cells with CS or LH
Freshly harvested W-256 ascites fluid was
added to medium 199 (containing 10%
horse serum). The final tumour cell concen-
tration was 106 cells/mI. One 5 ml aliquot
was placed in a culture flask, gassed with
95% 02/5% CO2 and incubated at 36°C
for 30 min; 1 mg CS dissolved in 0-1 ml
normal saline was added to a second 5 ml
aliquot before gassing and incubation. The
cells from each flask were then washed twice
in ice-cold Tyrode solution. Cell viability
was based on the nigrosin exclusion test;
this showed that <1% of the washed cells
from control and CS treated cultures were
stained. The cultures were then diluted
with ice-cold Tyrode solution and 104 cells
contained in 0 5 ml from each culture were
injected intravenously in 2 groups of 6 rats.
Lung colonies were counted 7 days later.
Similarly, W-256 cells were incubated with
LH (1 part undiluted LH added to 4 ml of
medium v/v) or with histamine, 5-hydroxy-
tryptamine or bradykinin (10-4 g drug/mI
medium final concentration); the incubated
cells -were washed in Tyrode solution, injected
intravenously in rats and assayed for colony
formation in the lungs of rats.
RESULTS
Pharmacological effects of ayents uised to
induce inflamm.ation
(i) Local tissue reaction7s.-Interdigital
injections of 1 ,ug of Compound 48/80
caused a definite (+) inflammatory reac-
tion in rats. The injected paw became
red, warm and swollen within 1-2 min;
some swelling remained 1 h later. Larger
doses (10-100 jug) 48/80 caused more
marked (++) reactions. Interdigital in-
jections of 10-1000 jag CS caused (+) to
+) inflammatory reactions which took
somewhat longer (5-10 min) to develop
than after 48/80. Verv marked inflamma-
tion of the paw was produced by an
interdigital injection of 041 ml LH (diluted
1 in 16 v/v). The swelling lasted for
2-3 h but had subsided after 24 h. JH
preparations were slightly acidic; neutral-
ization to pH 7-7.4 did not alter the
inflammatory response, but injection of
LH heated at 60°C for 30 min caused
less swelling of the paw.
(ii) Systemic effects and toxicity.-Corn-
pound 48/80 injected intraperitoneally in
doses of 100 ,ag or more causes mast cell
rupture, accompanied by the release of
biogenic amines particularly histamine
and 5-hydroxytryptamine (Lewis. 1958);
depletion is followed by resynthesis of the
autacoids in the tissues (Paton, 1951;
Riley and West, 1955). Compound 48/80
caused hypotension, pulmonary oedema
and an anaphylactic shock-like state
attributed principally to the release of
tissue histamine; rats injected with larger
doses (.500-1000 jag) 48/80 died from
haemorrhagic pulmonary oedema. Rats
injected with 5-10 mg CS/kg bodv weight
rapidly showed signs of shock and
dyspnoea but survived; rats injected with
> 10 mg CS/kg body weight died from
pulnionary haemorrhage and oedema.
CS does not release histamine but depletes
plasma kininogen and causes the release
of the peptide bradykinin. a mediator
of inflammation which is also largely
responsible for the toxic effects of intra-
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clotting of the blood and increases the
fibrinolytic activity of the blood (Roths-
child, 1968). We found that PGE1 and
PGF2a and bradykinin had no significant
effects oni blood clotting time. Compound
48/80 slightly shortened clotting time in
the rat. CS added to rat blood in vitro
prolonged clotting time, which was simi-
larly increased in the blood taken from
rats which had been injected with CS
(Fig. 1). The fibrinolytic effeet of CS
is most marked in rats injected with
1-3 mg CS/kg body weight; further
increase in dose to 10 mg CS/kg causes
fibrinolytic activity to decrease to normal,
whereas the anticoagulant effect of the
agent continues to increase with increase
in dose (Rothschild. 1968, Fig. 1). Neither
CS nor Compound 48/80 produces signi-
ficant changes in haematocrit levels, blood
platelets or plasma protein (Rothschild,
1968). How"Tever. both agents caused
leucocvte counts to increase by 30-10001'
within 15 nmim after injection.
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of LH injected intravenously in rats was
0 4 ml of diluted LH (1 part LH: 32
parts distilled water v/v). This dose
caused shock and respiratory difficulty,
from which rats rapidly recovered, but
did not alter blood clotting time. The
toxic effects of larger doses of LH were
similar to those produced by CS, i.e.
shock, cyanosis and respiratory difficulty,
except that LH caused rapid loss of
consciousness which was not preceded by
convulsions. Death often occurred before
there was evidence of pulmonary oedema
and haemorrhage and appeared to be due
to cardiac arrest, but these physiological
changes have not been investigated.
LIH caused rupture of mast cells in the
nmesenteries and subcutis of the rat. The
local and systemic effects ofLH resembled
those of Compound 48/80 and CS in the
rat, and it is assumed that the common
mechanism of action of the agents is
the release of mediators of inflammation
from the tissues of the animnal.
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FiG. 1. Effect of adding cellulose sulphate (CS) to rat blood in vitro (closed symbols), or of intra-
venously injecting rats with a single dose CS 10 min before bleeding (open symbols), on clotting
time of blood.
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Effects of CS, Compound 48/80 and LH
on CFE
A single intravenous injection of 10 mg
CS/kg body weight given shortly before
or after an intravenous injection of 5
x 103 W-256 tumour cells caused marked
increases in CFE in the lungs of 25-day
old rats (Table I). The greatest increase
in CFE (accompanied by -1400% increase
in lung weight due to tumour growth)
occurred when CS was injected 10 min
before the tumour cells. Stimulation of
CFE was decreased when CS was injected
2 h before or after the tumour cells, but
CFE was significantly raised even when
the cells were injected 24 h after CS. CS
had no significant effect on CFE when it
was injected 24 h after the tumour cells.
Consequently, the degree of stimulation
of CFE by CS appeared to depend on the
presence and intensity ofthe physiological
reaction (inflammation) induced in the
rat at the time of injection and implanta-
tion of the tumour cells, or in the first
few hours after seeding in the tissues;
as the inflammatory reaction resolved,
CFE decreased pari passu. Compound
48/80 injected, intraperitoneally in maxi-
mum tolerated dosage, also enhanced
CFE but to a lesser extent than CS. An
intravenous injection ofLH also stimulat-
ed CFE (Table II). CS and Compound
48/80 also stimulated CFE in rats which
were 6 weeks old (Table I, Fig. 2).
Between 4 and 6 weeks of age, CFE of
tumour cells in the lungs and other
organs of the rat has been shown to
decrease markedly, even if assays are
performed in rats given sublethal whole
body irradiation to suppress immunity
(van den Brenk et al., 1973a). Stimula-
tion of CFE by CS was dose-dependent
(Fig. 3). The dose-effect relationship for
CS on CFE correlates with the effect of
CS of inhibiting haemocoagulation (Fig.
1, 3) but not with its effect on fibrinolytic
activity (see above).
Effects of pharmacological mediators of
inflammation (biogenic amines, bradykinin
and prostaglandins) on CFE
Previous preliminary studies had
TABLE I.-Effect on CFE in Lungs of Female Rats Injected Intravenously with W-256
Tumour Cells of: (i) a Single Dose of 10 mg Cellulose Sulphate (CS) per kg Body
Weight Injected Intravenously 10 min-24 h Before or After the Injection ofTumour
Cells, (ii) 2 Doses of 1 mg Compound 48/80per kg Body Weight Injected Intraperiton-
eally 10 min Before and 3 h After the Injection of Tumour Cells. Weanling (25-day
old) Rats were Injected with 5 x 103 W-256 Cells and 6-week OldRats with 104 W-256
Cells. Eight Rats Per Group (W1 Mean Body Weight on Day - 1 and W2 Mean
Body Weight when Rats were Killed on Day + 7; Tumour Cells Injected on Day 0)
Treatment
25-day old rats
I. Nil
II. CS (-24 h)
III. CS (-2 h)
IV. CS (-10 min)
V. CS (+2 h)
VI. CS (+24 h)
VII. Compound 48/80
(-10 min, +3h)
Six-week old rats
VIII. Nil
IX. CS (-10 min)
X. Compound 48/80
(-10min, +3h)
WI W2
(g) (g)
64
62
61
63
63
60
65
119
111
113
108
104
103
103
103
103
106
154
141
142
Organ weight (g)
r A
NL Lungs
33±9
75±12
310±28
> 500*
123±26
26+ 14
125±22
0 84±0*02
0-87±0*02
1 06±0 06
1*68±0 15
0-96±0-04
0-84±0-04
0 92±0 04
Spleen
0-59±0-02
0 57±0 02
0585±0 03
0*55±0*02
0 54±0*03
0 59±0 03
0 59±0 02
Thymus
0 38±0-03
0-37±0-02
0-43±0 02
0-41±0 02
0 37±0 02
0-40±0-02
0-41±0-02
15±6 1-09±0-03 0-69±0-03 0-43±0-02
> 300* 1-60±0*15 0-62±0-04 0-49±0-02
137±43 1-22±0-16 0-66±0-04 0-41±0-02
* Estimates; colonies confluent in many parts of lungs; blood stained pleural effusions containing
106-107 tumour cells per ml were present in all rats in groups IV and IX, and in 3 rats in each of groups
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TABLE II. Effect on CFE in the Lungs of 0 4 ml Lung Homogenate Supernatant (LH)*
Diluted 1 in 32 with Distilled Water (v/v), Injected Intravenously in 6-week Old Rats
10 min Before the Intravenous injection of 5 x 103 W-256 Tumour Cells. Tumour
Macrocolonies were Counted 8 Days After the Tumour Cells were Injected (6 Rats
Per Group; Controls Injected Intravenously with 0 4 ml Distilled Water in Place of LH); W1, W2 Initial and Final Body Weights
Mlean body weight
(g)
Grotup W1 W2
Control 116±3 147±3
LH 1171-4 146 5
Number of
lung colonies
NL (range)
15a 1
(11-18)
65± 17
(20-136)
Organ weights
(g)
Lungs Spleen
0-98±0-02 0-69±0-02
* Undiluted LH containecl 33 -5 mg protein per ml.
TABLE III.-Effects on
Rats of (A) Histami?
hydroxytryptamine and
jected Intravenously at
with 5 x 102 W-256 C
staglandins PGE1 and
Added to Intravenouslp
P388 Cells. Compoun
the Cells Immediately
Mean Body Weights G
per Group) were W1 at
and W2 7 Days Later
Killed to Count Tumou
Added compoun(l(s)
(dose per rat)
A. I. Nil
II. 1 mg histamine
111. 0 5 mg 5-hydroxy-
tryptamine
IV. 1 ,g bradykinin
V. 1 ,Ig bradtykinin plus
1 mg histamine
VI. 1 ,Ig bradykinin
1 mg histamine
0 5 mg 5-hydroxy-
tryptamine
B. I. Nil (solvent)*
II. 100 ,ug PGEl
III. 00 ,ig PGF2a
There were no significant d
body weight (W2-W1), NL anc
spleen, thymus and lungs b
treate(c rats in experiments A i
* An equal volume of
buffer that was used to diss
for addition to injected cells
added to cells injected in I.
CzFE in Lungs of shown that CFE was not significantly
ae Phosphate, 5- affected by intravenous or intraperi- Bradykinin, In- toneal injection of rats with histamine,
id Simultaneously 5-hydroxytryptamine oradrenergic amines
ells, and (B) Pro- (noradrenaline, adrenaline, isopropylnor-
PGF2., Similarly adrenaline or methoxamine) in doses of
Injected 104 Y- one quarter to one half the LD50 level.
Ids were Added to given 5-10 min before the injection of
Before Injection. the tumour cells (unpublished data).
)f Rats (6-8 Rats Neither did CFE change when Compound Time of Injection 48/80 was administered daily for 3-10
e when Rats were days to deplete the tissue amines to less
r Colonies than 10% of normal values before the
Number injection of tumour cells (van den Brenk
of lung et al., 1973b). Also, the treatment of v 11V2 colonies rats with antihistaminic drugs had no
80 120 4+N1 effect on CFE (van den Brenk et al.,
84 123 5-4-2 1974). Table III shows the results of a
74 112 8±4 further experiment in which the autacoids
73 114 62-2 liberated by 48/80 and CS, namely
74 113 5 1 histamine, 5-hydroxytrvptamine and
86 118 914 bradykinin were injected intravenously, either singly or in combination, together
with W-256 tumour cells. These treat-
108 137 17±6 ments had no significant effects on CFE.
98 130 24±9 The prostaglandins, PGE1 and PGF2a, 98 128 25+7 added in doses of 100 ,ug to the tumour
cells immediately before intravenous in-
lifferences in gain in jection, also failed to stimulate CFE.
etwieen control and This dosage in rats was approximately
and B. 1 mg PG/kg body weight. The injection alcoholic-carbonate of PGE1 and PGF.2, added to the tumour olve prostaglandins
in II and III was cells caused shock accompanied byrespira- tory and vasomotor effects which did not
Thymus
043-0 01
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FIG. 3.-Number of tumour macrocolonies
produced in lungs of8-week old ratsinjected
with W-256 cells 10 min after a single dose
of cellulose sulphate had been injected
intravenously. Eight rats per point;
5 x 103 W-256 cells (closed symbols) and
103 cells (open symbols) were injected intra-
venously and colonies counted 8 days
later.
differ from those produced by injection
ofthe drugs alone in the same dosage.
Consequently, stimulation of CFE by
Compound 48/80 and CS, and probably
by tissue homogenate as well, does not
appear to be due directly to the individual
pharmacological effects of the autacoids
which are liberated in tissues and act as
mediators of inflammation (Brocklehurst,
1971; Di Rosa, Giraud and Willoughby,
1971), but rather to some other compo-
nent(s) of the inflammatory reaction.
Effects of CS on CFE in tumour immunized
rats
In our experience, the most efficient
method of immunizing the rat against
growth of allogeneic tumour cells is by
injecting intact tumour cells into the
muscle of the leg of the rat so that solid
tumour (1-2 g in weight) develops after
7-10 days growth, when the rat's im-
munity to growth of a second challenge
of the same tumour is greatly increased.
The TD5O value of a second challenge
of W-256 cells injected into the muscle
of the opposite leg was > 106 cells
compared with < 10 cells (primary chal-
lenge), and for intravenously injected
W-256 cells immunization reduced CFE
in the lungs < 0u0001 (van den Brenk et
al., 1973a). This method of immuniza-
tion was based on that of Haddow and
Alexander (1964) for growth of immuno-
genic methyleholanthrene induced sarco-
mata in the rat. These workers found
that the immunity produced in the rat
by a growing tumour was much greater
than that produced by repeated injections
of large numbers (106-107) of heavily
(lethally) irradiated (HR) cells over a
period of time. Table IV shows that in
rats immunized by the growth of a
primary challenge of W-256 cells in leg
muscle, CS did not reverse the effects
ofimmunity on the growth of a secondary
challenge-a finding which parallels that
obtained when local thoracic irradiation
was used to stimulate CFE of allogeneic
tumour cells in the lungs of rats (van den
Brenk et al., 1973b). The fact that CS
increased CFE by a factor of -, 15 in
unimmunized and in immunized rats
alike is taken to reflect a competition
between the inflammatory state induced
by CS and that of immunity on tumour
growth; each mechanism would appear
to act independently on survival and
growth of tumour cells. It is significant
that while inflammation did not directly
antagonize the action of tumour immu-
nity, it protected a proportion of newly
seeded tumour cells from immunodestruc-
tion for the time needed for these cells
to clone and thus increase CFE. Marked
splenic enlargement, which is produced
in immunized rats by the growth of
tumour, was not affected by CS, neither
did immunization or CS significantly
affect the weight ofthe thymus (Table IV).
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TABLE IV. Effect on CFE in Lungs of Rats of 10 mg CS per kg Body Weight Injected
Intravenously (IVI) 10min Before the Primary Challenge of 104 W-256 Tumour
Cells (IVI) in Unimmunized Rats (A and C) or Before the Secondary Challenge of
104 W-256 Cells (IVI) in Rats which Had Been Immunized Against This Tumour by
Allowing an Intramuscular Injection of 104 W-256 Cells to Grow for 7 Days Into a
Solid Tumour in the Right Leg (B). The Unimmunized Rats Used in (C) were
Injected Intramuscularly with 2 mg Dexamethasone 2 h before 10 mg CS per kg Body
Weight or an Equal Volume of Distilled Water was Injected IVI, Followed by 104
W-256 Cells IVI 10 min Later; Control Rats in Subgroups in A and B not Injected
with CS Also Received Equal Volumes of Distilled Water IVI; (6-8 Rats Per Group)
Weight of organs (g)
Group
Treatment W1* W2*
Wvi.
A
Not immunized
B
Immunizedtl
C
Not immunized;
Dexamethasone
th CS (g) (g) NL
- 84 150 26±9
(6-64)
+ 88 146 > 300
- 87 156 1±0 07
(0-3)
+ 85 143 15 - 6
(3-46)
- 87 125 15-5
(2-27)
-r 94 135 164± 28
(64-250)
Lungs
1-02
±0*01
1 31
±0 06
1 08
± 0 03
1 -12
±0-01
0 93
4-0 02
0.99
±0 03
Spleen
0 70
-4 -03
0-66
±0-02
1-08
±0 09
1 -15
+ 0- 17
0-60
+0 07
0 55
±0 03
Thymus
0 50
+005
0 50
-0 03
0 46
0 44
+0 03
0.15
+0 03
0-12
-tO Ol-0
* W1 mean body weight on Day -7 when rats in group B were immunized by injecting W-256 cells
intramuscularly; W2 mean body weight on Day +8 when rats were killedl (8 (lays after 104 W-256 cells IVI
on Day 0). Values for W2 group C rats were significantly lower due to decreased growth of rats following
the injection of the steroid on Day 0.
t All rats in both subgroups in B had developed large solid tumours in the right leg when killed on
Day + 8 weighing 2-5 g, and small (<1 g) to large (> 2 g) metastases in pelvic lymph nodes; there was no
significant difference between the 2 subgroups with respect to growth of the primary tumours or of lymph
node metastases.
TABLE V. Effect of 8 mg Cellulose Sulphate per kg Body Weight IVI 10 min Before
104 Y-P388 Cells IVI on Number of Lung Tumour Colonies (NL) Produced 8 Days
Later in 7-week Old Rats in which Bilateral Total Adrenalectomy (TAx) or Medullary
Adrenalectomy (MAx) had been Performed 2 Days Preceding the Injection of Tumour
Cells. W1 and W2 are Mean Body Weights on the Day of Operation and 10 Days
Later when Rats were Killed Respectively; 6-8 Rats Per Group
Group
(treatment)
I. Nil*
II. MA,,
III. TAx,
IV. CS*
V. MA,, plus CS
IV. TAX plus CS
Wi
(g)
157 ± 5
158±3
150± 4
156±4
156± 6
154± 4
W2
(g)
177 ±4
187± 5
157 +4
175± 5
180± 8
163± 5
NL
9±4
3±2
20 4 2
25±7
27 ± 3
r-
Lungs
1-08±0 02
1 22±0-03
1*00±0*01
1-08+0 03
1-25±0 06
1 02±0 04
Organ weight (g)
Spleen Thymus
0 79±0 05 0 43+0-01
0S89 0-04 0 55±0 04
0-69±0-04 0-38±0-02
0 75±0 06 0-41±0-04
1-02-' 0-06 0-50+0-06
0 77±0 03 0-39±0 02
* Anaesthetic only on the day adrenalectomies were performed in rats in other groups.
CFE in adrenalectomized rats
CFE of W-256 cells in the lungs of
totally adrenalectomized rats was slightly
reduced (P < 0.05). This reduction in
CFE may be related to inhibition of rate
of body growth after total adrenalectomy
(Table V). Bilateral medullary adrenal-
ectomy had less effect on both bodygrowth
and on tumour CFE. Neither total nor
medullary adrenalectomy prevented sti-
mulation of CFE by CS. This suggests
that the effect of CS on CFE is not due
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to the stress syndrome (Selye, 1950)
associated with the systemic release of
hormones (including adrenaline) from the
adrenals.
Reduction of effect of CS on CFE by
dexamethasone
A large single dose of 2 mg dexa-
methasone, an anti-inflammatory steroid,
injected intramuscularly 2 h before the
injection of CS, markedly reduced the
effect of CS on CFE (Table IV).
Assays of W-256 cells incubated with CS,
LH and mediators of inflammation
W-256 cells were incubated with 0*2 mg
CS per ml of medium. This concentra-
tion of CS (2 x 10-4 g per ml) was
chosen as approximately equal to the
mean concentration of CS produced in
the blood of rats by the intravenous
injection of the maximum tolerated dose
of 10 mg CS per kg body weight, assuming
that the agent is distributed uniformly
in the blood and the blood volume of the
rat is approximately 50 ml blood per
kg body weight. Rats injected intra-
venously with 104 W-256 cells incubated
with CS developed 27 + 7 lung colonies,
compared with 45 ± 27 colonies in rats
injected with 104 cells which had been
incubated without CS. It is concluded
that CS had no direct effect on the
survival or clonogenicity of W-256 cells.
Similarly, CFE of W-256 cells incubated
with LH or with the mediators histamine,
5-hydroxytryptamine and bradykinin, was
not significantly different from that of
cells incubated without the addition of
these agents (results not tabulated). The
final concentration (10-4 g per ml) of the
mediators present in the- incubation
medium greatly exceeded the local tissue
concentrations required to induce inflam-
matory oedema in rats, and the maximum
doses tolerated by rats (measured as dose
per unit body weight) when the drugs
were administered parenterally. The
mediators tested in vitro on sensitive
preparations ofcontractile rat and guinea-
pig tissues (including granulation tissue)
induced maximum contractile responses
at a concentration of less than 10-4 g
per ml in the test bath (unpublished data;
Gaddum, 1949; Majno et al., 1971).
Effect of anticoagulant treatment with
heparin on CFE
Anticoagulation treatment ofrats with
preservative-free heparin had no signifi-
cant effect on CFE (Table VI), even if
the rats had been given local thoracic
TABLE VI.-Effect on CFE in Lungs of
Rats of250 i.u. Preservative-Free Heparin
(0.05 ml) Added to W-256 Cells (Sus-
pended in 0 45 ml) and Injected Intra-
venously. Weanling Female Rats (6 Per
Subgroup) were given 1000 rad Local
Thoracic Irradiation* Under Anaesthesia
7 Days before the Injection of Tumour
Cells in Groups B, C and D to Increase
CFE; the Rats in Group A were not
Irradiated. Heparin was Added to the
Injected Cell Suspension in the 4 Sub-
groups Marked (II) Only
Group
A (I)
(II)
B (I)
(II)
C (I)
(II)
D (I)
(II)
N
Number of cells
injected
2 x103
2 x 103
102
102
5x 102
5x 102
103
103
NL
Number of lung
colonies
16±3
26±7
30±5
45±8
106± 16
105±20
161±15
183±25
* X-radiation technique has been described
previously (van den Brenk et al., 1973b).
irradiation 7 days before the cells were
injected to increase CFE as described
previously (van den Brenk et al., 1973b).
Similarly, CFE was not affected by
intraperitoneal injection of rats with
250 i.u. heparin 10 min before the tumour
cells were injected intravenously; the
results of this experiment were essentially
similar to those shown in Table V and are
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However, it was found that when
250 i.u. heparin containing 015a% chloro-
cresol as preservative was added to the
tumour cells, CFE was markedly reduced.
On the other hand, CFE was not signifi-
cantly affected by the same dose of
heparin (containing the preservative) if it
was injected intraperitoneally 10 min
before the intravenous injection oftumour
cells. Lung colony assays performed with
tumour cells which had been incubated
with 10-6 concentrations of chlorocresol
for 30 min showed that this substance is
highly toxic to tumour cells and reduced
CFE (unpublished data). The toxic
effects of the preservative employed in
preparing most brands of heparin used
in medicine may account for some experi-
mental findings in which treatment with
this anticoagulant was found to cause
modest reductions in growth of injected
tumour cells and in the development of
metastases.
Subcutaneous growth of tumour in inflaned
paw
Inflammation and swelling of the hind
paw of the rat were produced by the
interdigital injection of either 0.1 ml of
diluted (1: 4 v/v) LH, or 100 ,ug CS
dissolved in 0-1 ml distilled water. Ten
nmin later 10 W-256 cells suspended in
0-1 ml Tyrode solution were injected into
the swollen paw and also into the contra-
lateral (untreated) paw. In a group of
6 rats injected with LH palpable, actively
growing. haemorrhagic tumours developed
in the treated paws of 5 rats and no
tumours in untreated paws. The 5 tu-
mours were 2-10 mm in diameter at 21
days and continued to increase in size
for a further 7 days when the rats were
sacrificed. In the 6 rats treated with CS
similar sized tumours grew in 4 treated
paws, and in one rat a small tumour
(2 mm in diameter) had developed in the
untreated paw but was regressing. In
similar groups of rats injected with 33
or 100 W-256 cells tumours developed
in both the treated (CS or LH injected)
and untreated paws of all rats, but larger
tumours were present in the treated
paws of most rats, particularly in the
group injected with LH. In these ex-
periments the injection of tumour cells
into the swollen paw did not significantly
affect the rate of resolution of the inflam-
matory reactions; there was no swelling
of either paw 24 h after the injections.
DISCUTSSION
Cellular damage and death caused by
physical or chemical injury in the organism
evokes local vascular and other physio-
logical reactions at the site of injury,
accompanied by certain systemic reactions
which comprise inflammation. It is now
widely accepted that the inflammatory
reaction is mediated by the release of
certain autacoids substances present in
tissues which have been isolated and
chemically identified, and cause pharma-
cological reactions of a typically inflam-
matory nature (Di Rosa et al., 1971).
The most important known mediators of
inflammation are the biogenic amines.
histamine and 5-hydroxytryptamine, the
peptide bradykinin and a group of
cyclic oxygenated C20 fatty acids the
prostaglandins (Brocklehurst. 1971); other
pharmacologically active substances have
been extracted from tissues, such as SRS
(" slow reacting substance "). but their
role in inflammation is less certain.
Since inflammation produced by tissue
damage is the prelude to regeneration and
repair, which involves blastogenesis and
proliferative cell growth, it is reasonable
to suppose that acute inflammatory exu-
dates not only facilitate the growth of
normal tissue (repair) but might act
similarly with respect to tumour cells
owing to the presence ofgrowth promoting
substances (GSS). This supposition
prompted the experiments in which the
effects of inflammatory reactions induced
with Compound 48/80 and CS on survival
and clonogenic growth of tumour cells in
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were chosen because they cause cellular
injuries of a peculiar type, which release
biogenic amines and bradykinin from
tissues and cause local and systemic
reactions characteristic of the inflamma-
tory response. Since inflammation is
attributed to the biochemical action of
products of cell injury in vivo, the effects
of injecting rats with a preparation of
homogenized rat lung (LH) on tumour
growth was tested, since LH injected
subcutaneously induced a marked inflam-
matory reaction. We have shown that
parenteral administration of Compound
48/80, CS or LH greatly enhanced survival
and clonogenic growth in the lungs of
the rat ofintravenously injected allogeneic
tumour cells prepared in single cell
suspension. The growth of a small num-
ber of subcutaneously injected tumour
cells was similarly enhanced if the cells
were injected into inflamed tissue. We
have previously shown that local x-irra-
diation increased CFE of allogeneic
tumour cells in the lungs (van den
Brenk et al., 1973a) and in the liver
and kidnevs of the rat (van den
Brenk and Kelly, 1973c). The principal
effect of x-rays on tissues is inhibition
of proliferative cell growth; this results
in cell death which stimulates inflamma-
tion. We consider this inflammatory
state to be the principal cause of stimula-
tion of tumour growth in tissues damaged
by x-rays and other forms of injury.
The fact that treatment of rats with
anti-inflammatory steroids decreased stim-
ulation of tumour CFE produced by
x-rays (van den Brenk et al., 1974) and
by CS (Table I) supports this view.
The pharmacological changes induced
in rats by the injection of single large
doses of the individual mediators of
inflammation, histamine. 5-hydroxytrvpt-
amine, bradykinin and prostaglandins
PGE1 and PGF2,. did not result in
stimulation of CFE. This suggests that
the growth promoting effects of inflam-
mation depend on an integration of the
individual actions ofthe various mediators
released by tissue injury. However, al-
though both CS and Compound 48/80
stimulate CFE, CS predominantly releases
bradykinin, whereas Compound 48/80 re-
leases biogenic amines. This suggests
that some other agent is released from
injured tissues, or is contained in inflam-
matory exudates, which promotes growth
either alone or by complementing the
action of the mediators in this respect.
The fact that the incubation of tumour
cells with CS, Compound 48/80, LH or
pharmacological mediators of the inflam-
matory response did not affect their
viability or alter CFE indicates that the
growth promoting activity obtained in
vivo is associated with the inflammatory
exudate. Direct support for this view
is provided by the finding that repeated
intravenous injections of rats with freshly
harvested cell-free tumour ascites plasma
stimulated CFE, if large amounts (0.5-
1-0 ml) of the plasma were injected
intravenously at 60-90 min intervals
within 4 h after the tumour cells were
injected intravenously; heating the ascites
plasma at 60°C for 30 min abolished its
effect of stimulating CFE (unpublished
data).
Many workers have found that treat-
ment of mice and rats with anticoagulants
inhibited growth of transplanted tumours
and spread of metastases (Wood, Holyoke
and Yardley, 1961). Also, it has been
suggested that the presence of fibrin and
thromboplastin are important in increas-
ing take and growth of transplanted
tumours (Grossi, Agostino and Cliffton,
1960; Hewitt, Blake and Porter, 1973).
Clotting of blood and laying down of
fibrin also provides a support for the
growth of regenerating blood vessels
(Stearns. 1940a, b). However, CFE of
tumour cells in the lungs was not affected
by anticoagulant treatment with mucous
heparin, and was greatly stimulated by
CS. a synthetic heparin which is a powerful
anticoagulant and also increases fibrino-
lysis (Rothschild, 1968). However, it is
conceivable that the envelopment of
tumour cells by fibrin of clotted exudates
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of GSS produced by the tumour or the
tumour bed. This effect would seem to
be most important in supporting survival
and growth of single tumour cells which
seed in tissues. Thus, it has been shown
that local variations in the fluid micro-
environment and diffusion boundary layer
of cells greatly affects the dynamics of
growth (Stoker, 1973; Dulbecco and
Elkington, 1973). It is suggested that
the capacity of different types of tumours
to produce GSS varies widely and may
be a quality closely related to that of
malignant (autonomous) behaviour of a
tumour and may also affect the chances
of survival and clonogenicity of seeded
tumour cells. The feeder cell pheno-
menon in vitro (Puck and Marcus, 1956)
and the Revesz phenomenon in vivo
(Revesz, 1956) have demonstrated that
malignant cells produce GSS which greatly
affect clonogenic growth. The supple-
mentation of GCSS produced by the
tumour cell with GSS produced by the
tumour bed would increase CFE, particu-
larlv if the supply of GSS by host tissues
is augmented by inflammatory reactions.
We have shown that inflammation
induced in the tissues of the rat did not
prevent the actions of tumour-host im-
munity, established in the same animal,
of inhibiting growth of allogeneic tumour
cells; the two reactions, inflammation and
immunity, appeared to act independently
and to compete in determining the net
survival of the seeded tumour cells.
This finding parallels that previouslv
obtained for CFE of tumour cells seeded
in the irradiated lungs of immunized
rats (van den Brenk et al.. 1973b). It
was also found previously that the in-
flammatory reaction induced in rats with
Compound 48/80 increased early growth
of subcutaneously transplanted xeno-
genic murine cancer cells (van den Brenk
and IJpfill, 1958). It follows that stimula-
tion of tumour growth by inflammation
may be of much greater consequence
when tumour-host immunity is weak or
absent, as in spontaneous cancers or
grafted syngeneic tumours, than under
conditions ofcompetition with the marked
immunity produced by transplantation
of allogeneic and xenogenic tumours.
Since immune reactions result in cell
death, which induces inflammation per
se, a situation can arise wherein the
survival and growth of tumour cells are
inhibited by immunity but stimulated
by inflammation caused by the destruc-
tion of participating host and tumour
cells. The net result may be " immuno-
logical " enhancement of tumour growth.
Similarly. inflammatory reactions induced
by the injury and death of normal
tissues being replaced by growth of
solid tumours may contribute to "in-
vasiveness" and progressive growth of
solid tumours, even when immunity has
developed. Indeed, to a limited extent
tumour antigenicity conceivably favours
the " take ", growth and spread of the
tumour cell.
The mechanism involved in " cocar-
cinogenesis " appears to be closelv related
to and perhaps wholly due to a non-
specific growth promoting effect of
inflammation of tissues caused by "co-
carcinogens "; agents which have been
defined as physical or chemical agents
which " alone are not carcinogens, when
applied along with or after the application
of carcinogenic agents may increase the
carcinogenic effect ", and " precipitate
neoplasia in an area of tissue already
prepared for it by the previous applica-
tion of carcinogens "(Willis. 1950). This
interpretation of cocarcinogenesis is in
agreement with that of Menkin (1961),
who prepared a diffusible growth pro-
moting factor from inflammatory exudates
induced in rats, which was heat stable
and inactivated bv ribonuclease and
trypsin, and acted as a cocarcinogen in
mice and rabbits. Menkin reasoned that
the liberation of endogenous GSS by
inflammation offered a reasonable ex-
planation for the induction of repair
(regenerative growth). He also showed
that the growth promoting activity of
dialysates prepared from tissues of young
(actively growing) animals was morePROMOTION OF GROWTH OF TUMOUR CELLS IN ACUTELY INFLAMED TISSUES 259
pronounced than that of mature tissues.
We consider that the rapid decrease in
tumour CFE which occurs with decrease
in growth rate of the rat after weaning
(van den Brenk et al., 1973a) is largely
attributable to the same mechanisms,
namely, a decrease in tissue GSS. Also,
we suggest that the well established
effects of injury of stimulating growth
and of precipitating the clinical (overt)
manifestation of cancer in organs such
as breast. bone, testis and skin in man
(Willis, 1948) are due primarily to the
local growth promoting action of inflam-
mation induced by the injury and do
not basically difer from "cocarcino-
genesis ".
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